Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome

Kidney International

Volumn 58, Issue 3, 2000, Pages 1247-1252

  Hiraoka, Masahiro ^a,b,c,d,e,f   Tsukahara, Hirokazu ^a,b,c,d,e,f   Haruki, Shinichi ^a,b,c,d,e,f   Hayashi, Shuhei ^a,b,c,d,e,f   Takeda, Nobuaki ^a,b,c,d,e,f   Miyagawa, Kazuhiko ^a,b,c,d,e,f   Okuhara, Kenji ^a,b,c,d,e,f   Suehiro, Fumihiko ^a,b,c,d,e,f   Ohshima, Yusei ^a,b,c,d,e,f   Mayumi, Mitsufumi ^a,b,c,d,e,f   Furusho, K ^g   Itoh, S ^g   Nakazawa, Y ^g   Kato, E ^g   Konishi, K ^g   Shima, M ^g   Nishioka, K ^g   Momoi, T ^g   Maruyama, R ^g   Seto, S ^g   Hirao, T ^h   Suehiro, Y ^g   Uenoyama, H ^g   Sunagawa, A ^g   Takahashi, Y ^g   Okuda, A ^g   Mutoh, K ^g   more..

^a University of Fukui   (Japan)

^b FUKUI PREFECTURAL HOSPITAL   (Japan)

^c KURASHIKI CENTRAL HOSPITAL   (Japan)

^d Municipal Tsuruga Hospital   (Japan)

^e Kyoto Miniren Central Hospital   (Japan)

^f HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^g NONE   (Japan)

^h NONE   (Japan)

Author keywords

Corticosteroid toxicity; Dose of prednisolone; Frequent relapse of nephrotic syndrome; Gender and ESRD; Idiopathic nephrotic syndrome; Nephrotoxicity; Proteinuria

Indexed keywords

PREDNISOLONE;

ADOLESCENT; AGE; ARTICLE; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFICACY; FEMALE; HUMAN; IDIOPATHIC DISEASE; KIDNEY FAILURE; MALE; NEPHROTIC SYNDROME; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; SEX DIFFERENCE;

EID: 0033850194     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00279.x     Document Type: Article

References (24)

1. Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity: A report of the International Study of Kidney Disease in Children
2. Minimal change nephrotic syndrome, diffuse mesangial hypercellularity, and focal glomerular sclerosis
3. The nephrotic syndrome
4. Outcome of idiopathic childhood nephrotic syndrome: A 20 year experience
5. Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome
6. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children
7. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children: Arbeitsgemeinschaft fur Padiatrische Nephrologie
8. Short versus long initial prednisolone treatment in steroid-sensitive nephrotic syndrome in children
9. Minimal change disease
10. Longitudinal studies of lipoid nephrosis
11. Adult-onset minimal-change nephrotic syndrome: A long-term follow-up
12. Nephrotic syndrome: From toddlers to twenties
13. Influence of age at onset on the outcome of steroid-sensitive nephrotic syndrome
14. Early identification of frequent relapsers among children with minimal change nephrotic syndrome
15. Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children
16. Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome
17. Conventional therapy for idiopathic nephrotic syndrome in children
18. Treatment of the nephrotic syndrome associated with primary glomerulonephritis
19. Nephrotic syndrome in children: A randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early
20. Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome
21. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome
22. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence
23. Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: A multicentre randomized controlled trial: The French Society of Paediatric Nephrology
24. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial